SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Crowley R, Fitzgerald LH. The impact of cGMP compliance on consumer confidence in dietary supplement products. Toxicology 2006; 221: 9.
  • 2
    Sundgot-Borgen J, Berglund B, Torstveit KM. Nutritional supplements in Norwegian elite athletes—impact of international ranking and advisors. Scandinavian Journal of Medicine and Science in Sports 2003; 13: 138.
  • 3
    Sobal J, Marquart LF. Vitamin/mineral supplement use among athletes: a review of the literature. International Journal of Sport Nutrition 1994; 4: 320.
  • 4
    Erdman KA, Fung TS, Reimer RA. Influence of performance level on dietary supplementation in elite Canadian athletes. Medicine and Science in Sports and Exercise 2006; 38: 349.
  • 5
    Maughan RJ, Depiesse F, Geyer H. The use of dietary supplements by athletes. Journal of Sports Sciences 2007; 25: 103.
  • 6
    Striegel H, Simon P, Wurster C, Niess AM, Ulrich R. The use of nutritional supplements among master athletes. International Journal of Sports Medicine 2006; 27: 236.
  • 7
    World Anti Doping Agency. The 2008 Prohibited List. Downloaded from http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf [Accessed 01.04.2008].
  • 8
    Geyer H, Henze M, Machnik M, Mareck-Engelke U, Schrader Y, Sigmund G, Schänzer W. Health risks and doping risks of nutritional supplements. In Biomedical Side Effects of Doping, PetersC, SchulzT, MichnaH (eds). Sport und Buch Strauß: Köln, 2001; 141.
  • 9
    Ayotte C. Nutritional supplements and doping controls. IAAF-New Studies in Athletics 1999; 14: 37.
  • 10
    Catlin DH, Leder BZ, Ahrens B, Starcevic B, Hatton CK, Green GA, Finkelstein JS. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. The Journal of the American Medical Association 2000; 284: 2618.
  • 11
    Green GA, Catlin DH, Starcevic B. Analysis of over-the-counter dietary supplements. Clinical Journal of Sport Medicine 2001; 11: 254.
  • 12
    Kamber M, Baume N, Saugy M, Rivier L. Nutritional supplements as a source for positive doping cases? International Journal of Sport Nutrition and Exercise Metabolism 2001; 11: 258.
  • 13
    Prasrampuria M, Schwartz K, Petesch R. Quality control of dehydroepiandrosterone dietary supplement products. The Journal of the American Medical Association 1998; 8: 1565.
  • 14
    Schilt R, van der Vlis E, Waes W, Sterk SS, van Ginkel LA Onderzoek naar het voorkomen van dopinggeduide stoffen in voedingsmiddelen in de aanloop naar de olympische winterspelen in salt lake city. 2002; Downloaded from http://www2.sport.nl/attachments/TNOrapportvoedings supplementen.pdf (access date 01.04.2008).
  • 15
    De Hon O, Coumans B. The continuing story of nutritional supplements and doping infractions. British Journal of Sports Medicine 2007; 41: 800.
  • 16
    Parr MK, Geyer H, Sigmund G, Koehler K, Schaenzer W. Screening of nutritional supplements for stimulants and other drugs. In Recent Advances in Doping Analysis (11), SchaenzerW, GeyerH, GotzmannA, MareckU (eds). Sport und Buch Strauß: Köln, 2003; 67.
  • 17
    Jung J, Hermanns-Clausen M, Weinmann W. Anorectic sibutramine detected in a chinese herbal drug for weight loss. Forensic Science International 2006; 161: 221.
  • 18
    Vidal C, Quandte S. Identification of a sibutramine-metabolite in patient urine after intake of a “pure herbal” Chinese slimming product. Therapeutic Drug Monitoring 2006; 28: 690.
  • 19
    Koehler K, Geyer H, Guddat S, Orlovius A, Parr MK, Thevis M, Mester J, Schänzer W. Sibutramine found in chinese herbal slimming tea and capsules. In Recent Advances in Doping Analysis (15), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2007; 367.
  • 20
    Nisoli E, Carruba MO. A benefit-risk assessment of sibutramine in the management of obesity. Drug Safety 2003; 26: 1027.
  • 21
    Geyer H, Mareck-Engelke U, Reinhart U, Thevis M, Schänzer W. Positive doping cases with norandrosterone after application of contaminated nutritional supplements. Deutsche Zeitschrift für Sportmedizin 2000; 11: 378.
  • 22
    Geyer H, Mareck-Engelke U, Wagner A, Schänzer W. Analysis of “non -hormonal” nutritional supplements for prohormones. In Recent Advances in Doping Analysis (9), SchänzerW, GeyerH, GotzmannA, Mareck-EngelkeU (eds). Sport und Buch Strauß: Köln, 2001; 63.
  • 23
    Geyer H, Parr MK, Reinhart U, Schrader Y, Mareck U, Schänzer W. Analysis of Non-Hormonal Nutritional Supplements for Anabolic Androgenic Steroids—an International Study -. In Recent advances in doping analysis (10), SchänzerW, GeyerH, GotzmannA, MareckU. (eds). Sport und Buch Strauß: Köln, 2002; 83. eds).
  • 24
    Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schänzer W. Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids—results of an international study. International Journal of Sports Medicine 2004; 25: 124.
  • 25
    Gmeiner G, Hofer H. Untersuchung auf mögliche Verunreinigungen von Nahrungsergänzungsmitteln mit anabolen Steroiden. Forschungsberichte des Österreichischen Bundesministeriums für soziale Sicherheit und Generationen. ARC Seibersdorf research GmbH: Seibersdorf, 2002; 2.
  • 26
    Van Thuyne W, Delbeke FT. Validation of a GC-MS screening method for anabolizing agents in solid nutritional supplements. Biomedical Chromatography 2004; 18: 155.
  • 27
    Van der Merwe PJ, Grobbelaar E. Unintentional doping through the use of contaminated nutritional supplements. South African Medical Journal 2005; 95: 510.
  • 28
    Gmeiner G. Methandienon in Sportnahrung. Österreichisches Journal für Sportmedizin 2002; 2: 33.
  • 29
    Geyer H, Bredehöft M, Mareck U, Parr M, Schänzer W. Hohe Dosen des Anabolikums Metandienon in Nahrungsergänzungsmitteln gefunden. Deutsche Apotheker Zeitung 2002; 29: 50.
  • 30
    Geyer H, Bredehöft M, Mareck U, Parr MK, Reinhart U, Schänzer W. Oxandrolone and high doses of metandienone found in nutritional supplements. In Recent Advances in Doping Analysis (11), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sport und Buch Strauß: Köln, 2003; 77.
  • 31
    Geyer H, Bredehöft M, Mareck U, Parr MK, Schänzer W. High doses of the anabolic steroid metandienone found in dietary supplements. European Journal of Sport Sciences 2003; 3: 1.
  • 32
    Parr MK, Geyer H, Hoffmann B, Koehler K, Mareck U, Schänzer W. High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market. Biomedical Chromatography 2007; 21: 164.
  • 33
    Geyer H, Koehler K, Mareck U, Parr MK, Schänzer W, Thevis M. Nutritional supplements cross contaminated and faked with prohormones, “classic” anabolic steroids and “designer steroids”. Effectivness of the Antidoping Fight. 2006 IAAF World Anti Doping Symposium. IAAF: Monaco, 2007; 95.
  • 34
    Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicology Letters 2005; 158: 167.
  • 35
    Geyer H, Mareck U, Köhler K, Parr MK, Schänzer W. Cross-contaminations of vitamin- and mineral-tablets with metandienone and stanozolol. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 11.
  • 36
    Parr MK, Opfermann G, Schänzer W. Detection of new 17-alkylated anabolic steroids on WADA 2006 list. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 249.
  • 37
    Ayotte C, Gouderault D, Cyr D, Gauthier P, Larochelle D, Poirer D. Characterisation of chemical and pharmacological properties of new steroids related to athletes. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 151.
  • 38
    Kazlauskas R. Miscellaneous projects in sports drug testing at the National Measurement Institute, Australia, 2005. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 129.
  • 39
    Van Eenoo P, Spaerkeer A, Lootens L, Van Thuyne W, Deventer K, Delbeke FT. Results of several (small) research projects at DoCoLab in 2005. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 79.
  • 40
    Rodchenkov G, Sobolevsky T, Sizoi V. New designer anabolic steroids from internet. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 141.
  • 41
    Parr MK, Opfermann G, Schänzer W. Analytical properties of 4-hydroxysteroids and some esters. In Recent Advances in Doping Analysis (12), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sport und Buch Strauß: Köln, 2004; 129.
  • 42
    Kohler M, Parr MK, Opfermann G, Schänzer W. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone. In Recent Advances in Doping Analysis (14), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2006; 169.
  • 43
    Kohler M, Parr MK, Opfermann G, Thevis M, Schlörer N, Marner FJ, Schänzer W. Metabolism of 4-hydroxyandrostendi- one and 4-hydroxytestosterone: mass spectrometric identification of urinary metabolites. Steroids 2007; 72: 278.
  • 44
    Parr MK, Geyer H, Opfermann G, Schänzer W. Prescription drugs and new anabolic steroids in nutritional supplements. In Recent Advances in Doping Analysis (12), SchänzerW, GeyerH, GotzmannA, MareckU. (eds). Sport und Buch Strauß: Köln, 2004; 71.
  • 45
    Parr MK, Kazlauskas R, Schlörer N, Opfermann G, Piper T, Schulze G, Schänzer W. 6a-methylandrostendione: gas chromatographic mass spectrometric detection in doping control. Rapid Communications in Mass Spectrometry 2008; 22: 321.
  • 46
    Van Eeno P, Mikulcikova P, Deventer K, Van Thuyne W, Delbeke FT. Metabolism, excretion and detection of androst-4-ene-3,6,17-trione. In Recent Advances in Doping Analysis (13), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2005; 57.
  • 47
    Van Thuyne W, Van Eenoo P, Mikulcíková P, Deventer K, Delbeke FT. Detection of androst-4-ene-3,6,17-trione (6-OXO) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis. Biomedical Chromatography 2005; 9: 689.
  • 48
    Parr MK, Opfermann G, Piper T, Schlörer N, Fußhöller G, Thomas A, Thevis M, Schänzer W. Characterisation of steroid metabolites recently detected in doping control analyses. In Recent Advances in Doping Analysis (15), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2007; 143.
  • 49
    Kazlauskas R. Supplements and WADA list. In Recent Advances in Doping Analysis (15), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2007; 31.
  • 50
    Delbeke FT, Van Eenoo P, Van Thuyne W, Desmet N. Prohormones and sport. The Journal of Steroid Biochemistry and Molecular Biology 2002; 83: 245.
  • 51
    Van Eenoo P, Lootens L, Van Thuyne W, Deventer K, Pozo-Mendoza O, Delbeke FT. Results of several (small) research projects at DoCoLAb in 2006. In Recent Advances in Doping Analysis (15), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2007; 41.
  • 52
    Parr MK, Geyer H, Gütschow M, Haenelt N, Opfermann G, Thevis M, Schänzer W. New steroids on the “Supplement” market. In Recent Advances in Doping Analysis (15), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sportverlag Strauß: Köln, 2008 (in press).
  • 53
    US Drug Enforcement Administration. Anabolic Steroids ControlAct, 2004; available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_cong_bills&docid= f : h3866rfs.txt. pdf (accessed 31 October 2005).
  • 54
    Parr MK, Koehler K, Geyer H, Guddat S, Schänzer W. Clenbuterol marketed as dietary supplement. Biomedical Chromatography 2008; 22: 298.
  • 55
    Thevis M, Schänzer W. Mass spectrometry in sports drug testing: structure characterization and analytical assays. Mass Spectrometry Reviews 2007; 26: 79.
  • 56
    Thevis M, Schänzer W. Mass spectrometry in doping control analysis. Current Organic Chemistry 2005; 9: 825.
  • 57
    Diekman J, Djerassi C. Mass spectrometry in structural and stereochemical problems. CXXV. Mass spectrometry of some steroid trimethylsilyl ethers. Journal of Organic Chemistry 1967; 32: 1005.
  • 58
    Horning EC, Brooks CJW, Vanden Heuvel WJA. Gas phase analytical methods for the study of steroids. In Advances in Lipid Research, vol. 6, PaolettiR, KritchevskyD (eds). Academic Press: New York, 1968; 273.
  • 59
    Vouros P, Harvey DJ. Method for selective introduction of trimethylsilyl and perdeuterotrimethylsilyl groups in hydroxy steroids and its utility in mass spectrometric interpretations. Analytical Chemistry 1973; 45: 7.
  • 60
    Dürbeck HW, Büker I. Studies on anabolic steroids. The mass spectra of 17 alpha-Methyl-17 beta-hydroxy-1,4-androstadien-3-one (Dianabol) and its metabolites. Biomedical Mass Spectrometry 1980; 7: 437.
  • 61
    Schänzer W, Horning S, Opfermann G, Donike M. Gas chromatography/mass spectometry identification of long-term excreted metabolites of the anabolic steroid 4-chloro-1,2-dehydro-17alpha-methyltestosterone in humans. Journal of Steroid Biochemistry and Molecular Biology 1996; 57: 363.
  • 62
    Schänzer W, Donike M. Synthesis of Deuterated Steroids for GC/MS Quantification of Endogenous Steroids. In Recent Advances in Doping Analysis, DonikeM, GeyerH, GotzmannA, Mareck-EngelkeU (eds). Sport und Buch Strauß: Köln, 1994; 94.
  • 63
    Donike M, Ueki M, Kuroda Y, Geyer H, Nolteernsting E, Rauth S, Schanzer W, Schindler U, Volker E, Fujisaki M. Detection of dihydrotestosterone (DHT) doping: alterations in the steroid profile and reference ranges for DHT and its 5 alpha-metabolites. The Journal of Sports Medicine and Physical Fitness 1995; 35: 235.
  • 64
    Schänzer W, Geyer H, Donike M. Metabolism of metandienone in man: identification and synthesis of conjugated excreted urinary metabolites, determination of excretion rates and gas chromatographic- mass spectrometric identification of bis-hydroxylated metabolites. The Journal of Steroid Biochemistry and Molecular Biology 1991; 38: 441.
  • 65
    Schänzer W, Opfermann G, Donike M. 17-Epimerization of 17 alpha- methyl anabolic steroids in humans: metabolism and synthesis of 17 alpha- hydroxy- 17ß- methyl steroids. Steroids 1992; 57: 537.
  • 66
    Schänzer W, Donike M. Metabolism of boldenone in man: gas chromatographic/mass spectrometric identification of urinary excreted metabolites and determination of excretion rates. Biological Mass Spectrometry 1992; 21: 3.
  • 67
    Houghton E, Dumasia MC, Teale P, Smith SJ, Cox J, Marshall D, Gower DB. The use of stable isotopes and gas chromatography/mass spectrometry in the identification of steroid metabolites in the equine. Steroids 1990; 55: 433.
  • 68
    Schänzer W, Geyer H, Fusshöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine. Rapid Communications in Mass Spectrometry 2006; 20: 2252.
  • 69
    Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang Y-C, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Communications in Mass Spectometry 2004; 18: 1245.
  • 70
    Thevis M, Geyer H, Mareck U, Schänzer W. Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. Journal of Mass Spectrometry 2005; 40: 955.
  • 71
    Pozo OJ, Van Eenoo P, Deventer K, Delbeke FT. Development and validation of a qualitative screening method for the detection of exogenous anabolic steroids in urine by liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry 2007; 389: 1209.
  • 72
    Thevis M, Opfermann G, Bommerich U, Schänzer W. Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry 2004; 40: 494.
  • 73
    Thevis M, Schänzer W. Mass spectrometric analysis of androstan-17beta-ol-3-one and androstadiene-17beta-ol-3-one isomers. Journal of the American Society for Mass Spectrometry 2005; 16: 1660.
  • 74
    Geyer H, Gülker A, Mareck U, Parr MK, Schänzer W. Some good news from the field of nutritional supplements. In Recent Advances in Doping Analysis (12), SchänzerW, GeyerH, GotzmannA, MareckU (eds). Sport und Buch Strauß: Köln, 2004; 91.